Physician profile
Frederick T Hodges
NPI 1619909231
$805.66
in general payments reported to CMS, 2019-2025
10 companies · $509 in 2025
The $509 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $27.58 · 2023: $134 · 2024: $135 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $281.88 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $128.04 | 2025 | Veozah |
| Medtronic, INC. | $101.44 | 2023 | Concertotm |
| Lilly USA, LLC | $86.00 | 2025 | Zepbound |
| Pacira Pharmaceuticals Incorporated | $67.85 | 2024-2025 | Exparel |
| Exeltis, USA INC. | $40.28 | 2024-2025 | Slynd |
| Organon LLC | $38.76 | 2023-2025 | Nexplanon |
| Abbvie INC. | $35.40 | 2020-2023 | |
| Merck Sharp & Dohme LLC | $13.72 | 2025 | Gardasil 9 |
| Allergan, INC. | $12.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Hodges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.